Browsing Tag
Plus Therapeutics
3 posts
Plus Therapeutics wins major reimbursement milestone as Humana approves CNSide cerebrospinal fluid assay
Find out how Plus Therapeutics secured Humana’s national coverage for the CNSide assay and what it means for metastatic CNS cancer care today.
Investors eye Plus Therapeutics after promising ReSPECT-LM results and FDA fast-track push for REYOBIQ in brain metastases
See how Plus Therapeutics’ REYOBIQ delivered >75 percent benefit and no toxicity in its ReSPECT-LM trial—discover what this means for CNS cancer treatment and investors.
Biocept and Plus Therapeutics sign licensing deal for CNSide technology
Biocept, Inc. and Plus Therapeutics, Inc. have entered a non-exclusive licensing agreement expanding their existing laboratory services. Under…